Kneu Health raises £4m seed round co-led by Oxford Science Enterprises and Cedars-Sinai to scale precision neurology platform

Kneu Health develops a precision neurology platform that uses smartphone-based data and clinically trained AI models to monitor Parkinson’s and dementia continuously, supporting earlier intervention and more proactive neurological care.